Bionomics Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BNOEF research report →
Companywww.bionomics.com.au
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia.
- CEO
- Spyridon Papapetropoulos
- IPO
- 2014
- HQ
- Eastwood, SA, AU
Price Chart
Valuation
- Market Cap
- $8.81M
- P/E
- -0.07
- P/S
- -1.70
- P/B
- 0.91
- EV/EBITDA
- -0.01
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 98.95%
- Op Margin
- 7308.31%
- Net Margin
- 2468.88%
- ROE
- -1538.96%
- ROIC
- -1553.34%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-15,492,166,000 · -72936.61%
- EPS
- $-1898.55 · -52637.50%
- Op Income
- $-17,892,376,000
- FCF YoY
- -3.27%
Performance & Tape
- 52W High
- $0.06
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.02
- Beta
- 1.84
- Avg Volume
- 91.84K
Get TickerSpark's AI analysis on BNOEF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BNOEF Coverage
We haven't published any research on BNOEF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BNOEF Report →